- Home
- Provider Administrative newsletter
- Medicare Advantage, Interqual update, and provider enrollment changes in September 2023
Medicare Advantage, Interqual update, and provider enrollment changes in September 2023
Featured story: School restart: Helping kids adjust to a new morning routine
Even if your kids have a reason to get up early over summer break — whether it’s getting dropped off at day camp or going to a friend’s house — it’s a fact that summer tends to include much less structure than they have during the school year. The Centers for Disease Control and Prevention note that children and teens who don’t get enough sleep are at higher risk for problems with attention, as well as more mental health issues, yet nearly 60% of middle-school students and over 72% of high-school students don’t get enough sleep on school nights.
In this issue:
- Medicare Advantage annual election period
- Interqual update
- Join our quality program committee to help improve the quality and effectiveness of our care
- Continuity of care-Mass General Brigham ACO
- Provider enrollment changes
- Mass General Brigham Health Plan’s Drug fee schedules to be updated
- Medical policy updates
- Formulary updates
- Code updates
- Drug code updates
Medicare Advantage annual election period
Hours changing
•Verify patient eligibility
•Verify claims status
•Submit or check authorizations/referrals
•Access your explanation of payments (EOPs)
•View member and provider roster reports
•Update your practice information
If you do not have access to Our Provider Portal, you can register at: massgeneralbrighamhealthplan.org/providers/portal
In September Mass General Brigham Health Plan will be moving to the 2023 InterQual Criteria for all products. Effective 10/01/2023 you will be required to provide a diagnosis code in the Provider Portal to ensure timely processing of authorization requests without having to call for more information.
Home care authorizations-
- Current day authorization is continuously revised. Which requires IT assistance.
- Going forward Home Care authorizations will be restricted to a 1 year date span.
Portal enhancements for Peer to Peer (P2P) requests and authorization closure legend
To improve the in-network provider experience for P2P requests, we've added a new enhancement to the provider portal for these requests.
Things to keep in mind for P2P requests on our provider portal:
-
- Do not enter P2P requests on this site for vendors such as CVS Caremark/Novologix or eviCore. For these go directly to the vendor for P2P/appeal
- These can only be requested for a medical necessity denial
- P2P request must be made within 30 days of the date on the denial letter
Any request not meeting the criteria above will be closed.
In addition, an authorization closure legend has been added to all user guides for the most frequently used authorization closure reasons. This feature has been added to provide clarification around closure reasons.
Join our quality program committee to help improve the quality and effectiveness of our care
Mass General Brigham Health Plan is seeking provider membership (including all MD specialties, NPs, and PAs) for its Quality Program Committee (QPC) to share expertise on topics that will ensure the quality and effectiveness of the care delivered to its members. Committee members have the opportunity to weigh in on a variety of health plan topics including:
- Network adequacy;
- Utilization Management and Medical Necessity Procedures;
- Member experience and satisfaction;
- Identifying and addressing potential health care disparities and inequities.
The QPC meets virtually on the third Wednesday every other month for 90 minutes.
The meeting dates for the rest of 2023 are:
- Wednesday, October 18th 7:30 a.m.-9:00 a.m.
- Wednesday, December 20th 7:30-9:00 a.m.
If you are interested in joining the QPC, please contact Elaine Alden at Ealden@allwayshealth.org indicating your interest and we will reach out with information on the next steps regarding your participation. Some providers may qualify to earn $300 per meeting. Please feel free to contact us with any questions regarding your eligibility for this and/or any other questions that you may have about the Committee.
We appreciate the opportunity to collaborate with our provider network and thank you for the care you provide our members.
Continuity of care-Mass General Brigham ACO
Our continuity of care (CoC) period through 8/31/23 for the Mass General Brigham ACO, has now ended.
As a reminder, in the event of active ongoing services with an OON provider, after 8/31/23, the provider must submit the request for continued service via our Mass General Brigham Health Plan Provider Portal. If the current authorization with the in network provider has expired (past 8/31/23), and the member still requires the service, then the provider will need to submit a request for prior authorization. These are considered a new request for services and not Continuity of Care as the previously approved services auth has ended and will be reviewed by our Utilization Management Team.
Here's what providers should know:
- Please ensure prior authorizations (PA) are submitted with all required documentation for all services that require PA. For more info, click here
- Members will need prior authorization to see specialists out of network. See our provider directory for more information.
- Prior authorizations should be submitted via our provider portal
For more information and tools regarding the MGB ACO please visit: Mass General Brigham ACO | Mass General Brigham Health Plan
For questions, contact our Provider Service Center at 855-444-4647 or via email at healthplanproviderservice@mgb.org
Provider enrollment changes
The Centers for Medicare & Medicaid Services and other regulatory bodies, as well as the federal No Surprises Act of 2021, require health plans to maintain and update data in provider directories. We rely on providers to review their data and notify us of changes as they happen, this ensures members have access to accurate information.
Provider demographic information in our Provider Directory must reflect accurate data at all times and should mirror the information members may receive directly from the practice or via patient appointment call centers.
To keep accurate network provider information, Mass General Brigham Health Plan must be promptly notified in writing of relevant changes pertaining to a provider’s practice. The primary way to notify Mass General Brigham Health Plan of enrollment changes is through the Provider Enrollment Portal within the Mass General Brigham Health Plan Provider Portal https://provider.massgeneralbrighamhealthplan.org/Authentication/LogIn?ReturnUrl=%2F.
The Provider Enrollment Portal gives you easy access to submit requests such as the following:
- Enroll a new provider into your group
- Terminate an existing provider from your group
- Open and close your panels
- Submit demographic changes
- Generate a complete HCAS form
The Provider Enrollment Portal gives you real-time status information on your enrollment request as well as sends you an email notification when your request has been completed.
Providers can also submit provider enrollment changes via the following tools:
- Provider directory information landing page: Update directory | Mass General Brigham Health Plan
- Standardized Information Change Form http://www.masscollaborative.org/Provider_Information_Change_Form.pdf or with a signed document on the provider’s stationery. Completed forms should be emailed to HealthPlanPEC@mgb.org. Verbal requests and/or those submitted by third-parties or billing agents not on record as authorized to act on a provider’s behalf cannot be accepted.
In addition, please keep the following in mind:
- Practice location — As new providers join your practice, it is important that only practice locations where the provider regularly administers direct patient care are submitted for inclusion in the Mass General Brigham Health Plan provider directory. Locations in which a provider may occasionally render indirect care — such as interpretation of tests or inpatient-only care — should be specified to ensure the location information is included in the provider’s demographic profile, but not in the provider directory.
- Timely notice — As a reminder, notification of address, acceptance of new patients, provider terminations, and other demographic information changes should be submitted at least 30 days in advance.
For questions, contact our Provider Service Center at 855-444-4647 or HealthPlanProvidersService@mgb.org
A message for OT/PT/ST providers in the ACO network
Reminder: Prior Authorization (PA) is required for therapy services Please visit PA requirements page for more information: Authorization guidelines | Mass General Brigham Health Plan
Mass General Brigham Health Plan’s Drug fee schedules to be updated
Mass General Brigham Health Plan reviews its drug fee schedules quarterly to ensure that they are current, comprehensive and consistent with industry standards, to the extent supported by its systems. In most cases, changes involve adding fees for new or existing codes, to supplement the fees already on the fee schedule.
The next update will occur on October 1, 2023. Changes may involve both new and existing CPT and HCPCS codes, and will include the planned quarterly update to physician administered drugs, immune globulin, vaccine and toxoid fees.
Medical policy updates
Four medical policies were reviewed and passed by the Mass General Brigham Health Plan’s Medical Policy Committee. These policies are now posted to MassGeneralBrighamHealthPlan.org. The table below is a summary.
For more information or to download our medical policies, go to https://www.massgeneralbrighamhealthplan.org/providers/medical-policies and select the policy under the medical policy listings.
Medical Policies |
|||
Policy Title |
Summary |
Products Affected |
Effective Date |
Hemgenix [NEW POLICY] |
Effective Date: Guidelines to determine the medical necessity for Hemgenix for the treatment of patients with Hemophilia B (congenital Factor IX deficiency). |
Commercial and Medicare Advantage |
8/1/2023 |
Specialty Medication Administration – Site of Care |
September 2023: Annual Review. Medicare language added. References updated. |
Commercial and Connector/Qualified Health Plans |
9/1/2023 |
Outpatient Drug Screening and Testing |
September 2023: Annual update. Medicare Advantage added to table. Medicare Variation language added. References updated |
All products |
9/1/2023 |
Non-Emergency Medically Necessary Transportation |
September 2023: Annual update. Medicare Advantage added to table 1. Medicare Variation language added. References updated. |
All products |
9/1/2023 |
In addition, as of August 2023, Mass General Brigham Health Plan customized InterQual criteria and published new guidelines. The following criteria was customized and created:
- Reduction Mammoplasty, Male (MassHealth) (Custom) – MGB
This customization was done to distinguish the criteria after adopting recent MassHealth updated Medical Necessity Guidelines.
Also, Mass General Brigham Health Plan customized InterQual criteria and published a new guideline.
- CP: Imaging. The guidelines are called Imaging, Knee (Custom) - MGB
To access this criteria, providers should log in to Mass General Brigham Health Plan’s provider website at MassGeneralBrighamHealthPlan.org and click the InterQual® Criteria Lookup link under the Resources Menu.
Code updates
The following service(s) are covered with prior authorization required for Commercial/ASO and Medicare Advantage Plans:
Code |
Description |
Effective Date: *Note the effective date applies to the code and not the drug |
J0174 |
Injection, lecanemab-irmb, 1 mg |
07/06/2023 |
The following service(s) are covered with prior authorization required for Commercial/ASO and Medicare Advantage Plans; Not reimbursable for MGB ACO Plans:
Code |
Description |
Effective Date |
J9029 |
Injection, nadofaragene firadenovec-vncg, per therapeutic dose |
07/01/2023 |
The following service(s) are covered with no prior authorization required for Medicare Advantage Plans:
Code |
Description |
Effective Date |
27279 |
Arthrodesis, sacroiliac joint, percutaneous or minimally invasive (indirect visualization), with image guidance, includes obtaining bone graft when performed, and placement of transfixing device |
08/01/2023 |
C9150 |
Xenon xe-129 hyperpolarized gas, diagnostic, per study dose |
07/01/2023 |
C9784 |
Gastric restrictive procedure, endoscopic sleeve gastroplasty, with esophagogastroduodenoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components |
07/01/2023 |
C9785 |
Endoscopic outlet reduction, gastric pouch application, with endoscopy and intraluminal tube insertion, if performed, including all system and tissue anchoring components |
07/01/2023 |
C9786 |
Echocardiography image post processing for computer aided detection of heart failure with preserved ejection fraction, including interpretation and report |
07/01/2023 |
C9787 |
Gastric electrophysiology mapping with simultaneous patient symptom profiling |
07/01/2023 |
Q4272 |
Esano a, per square centimeter |
07/01/2023 |
Q4273 |
Esano aaa, per square centimeter |
07/01/2023 |
Q4274 |
Esano ac, per square centimeter |
07/01/2023 |
Q4275 |
Esano aca, per square centimeter |
07/01/2023 |
Q4276 |
Orion, per square centimeter |
07/01/2023 |
Q4277 |
Woundplus membrane or e-graft, per square centimeter |
07/01/2023 |
Q4278 |
Epieffect, per square centimeter |
07/01/2023 |
Q4280 |
Xcell amnio matrix, per square centimeter |
07/01/2023 |
Q4281 |
Barrera sl or barrera dl, per square centimeter |
07/01/2023 |
Q4282 |
Cygnus dual, per square centimeter |
07/01/2023 |
Q4283 |
Biovance tri-layer or biovance 3l, per square centimeter |
07/01/2023 |
Q4284 |
Dermabind sl, per square centimeter |
07/01/2023 |
E0711 |
Upper extremity medical tubing/lines enclosure or covering device, restricts elbow range of motion |
04/01/2023 |
The following service(s) are covered when prior authorized for MGB ACO Plans:
Code |
Description |
Effective Date |
33289 |
Transcatheter implantation of wireless pulmonary artery pressure sensor for long-term hemodynamic monitoring, including deployment and calibration of the sensor, right heart catheterization, selective pulmonary catheterization, radiological supervision and interpretation, and pulmonary artery angiography, when performed |
01/01/2023 |
Formulary Updates
DEFINITIONS
Formulary These drugs are included in Mass General Brigham’s covered drug list.
Non-Formulary These drugs are not included in Mass General Brigham’s formulary. The plan would only cover formulary alternatives. Providers can request Non-Formulary drugs as an exception, and the plan would require trial of all appropriate formulary alternatives prior to approving coverage of a Non-Formulary drug. If a Non-Formulary drug is approved, the member’s cost sharing would be the highest tier.
Preferred These drugs are on Mass General Brigham’s formulary and offer a lower cost to members.
Non-Preferred These drugs are on Mass General Brigham’s formulary but offer a higher cost to members.
Excluded Mass General Brigham does not cover these drugs. Members will receive a denial for all Excluded drug requests.
Updates for Commercial Members
Effective 11/01/2023
The following changes are being made to the listed medications:
Rezurock |
This drug will require prior authorization. |
Updates for MassHealth Members
The following changes are being made to the listed medications to be in compliance with the MassHealth UPPL (Unified Pharmacy Product List):
Effective ASAP
Opioid Dependence and Reversal Agents |
Over-the-counter Naloxone has been added to the pharmacy benefit as covered. |
Effective 10/01/2023
Pharmaceutical Compounding Program
|
Reminder that Mass General Brigham Health Plan will align with the MassHealth Compounding Program no later than 10/01/2023. *Please note, individual drug PA criteria must be met first in order for approval of a compound* The following will require a prior authorization for compounded pharmaceutical products (with the exception of infusion, intravenous, intravenous piggyback, intravenous push, and subcutaneous routes of administration): · With a total cost of greater than or equal to $100 · With topical route of administration |
Effective 11/01/2023
Lymepak Valsartan Solution
|
The following medications have been added to the pharmacy benefit with prior authorization required and added to the federal rebate program. |
Metformin ER 625 mg tablet
|
The following medications will remain on the pharmacy benefit with prior authorization and added to the federal rebate program. |
Amzeeq Zilxi |
The following medications have been added to the pharmacy benefit with prior authorization and removed from the federal rebate program. |
Exelderm Ximino
|
The following medications will remain on the pharmacy benefit with prior authorization and removed from the federal rebate program. |
Opioid Dependence and Reversal Agents
|
LifEMS was added to the pharmacy benefit with prior authorization and quantity limit of 2 kits per 365 days. |